z-logo
open-access-imgOpen Access
In setback for potential Ebola drug, company halts trial
Author(s) -
Gretchen Vogel
Publication year - 2015
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aac6876
Subject(s) - setback , ebola virus , drug , virology , business , medicine , pharmacology , political science , outbreak , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom